What is in-space manufacturing, and what can be made in orbit?
Space Bandits · 17 November 2026
In short
- In orbit, liquids don't churn and crystals don't sink. That can produce purer crystals for drugs and chips, and better optical fibre.
- Shuttle-made "space beads" from 1983 were one of the first products made in space and sold on Earth. Nothing made in orbit is on sale today.
- Bringing products home is the bottleneck. Varda's first capsule waited in orbit for months before US regulators let it land in 2024.
- Varda expects to fly its first drug for United Therapeutics in 2027. Its CEO doesn't expect a patient to receive a drug made this way before 2030.
On Earth, gravity stirs every liquid. Warm fluid rises and cool fluid sinks, and anything heavier than the liquid settles to the bottom. In orbit, both effects nearly disappear. Some materials come out better without them. In-space manufacturing is the attempt to make those materials in orbit and sell them on Earth.
Why make things in space
NASA puts it in one sentence: microgravity "greatly reduces buoyancy-driven convection, hydrostatic pressure, and sedimentation" (NASA).
That matters most for crystals. JAXA explains why protein crystals grow better in space. With no convection, molecules reach the growing crystal only by slow diffusion, so it grows slowly and evenly. And the crystals don't sink to the bottom of the container, as they do on Earth (JAXA). Protein crystals are how many drugs are studied, and sometimes how they are stored and delivered.
The same applies to other materials:
- Semiconductors. More than 160 semiconductor crystals have been grown in microgravity since Skylab. Over 80% improved in at least one way, such as structure, uniformity or fewer defects (NASA).
- Optical fibre. A glass called ZBLAN could carry light better than the silica fibre used today. On Earth, gravity makes it crystallise while it is drawn into fibre (The Register). NASA says microgravity "significantly reduces the quantity of defects" in ZBLAN made in space.
- Tissue. NASA says that in microgravity, tissues "can be formed in three dimensions without supporting architecture" (NASA). Brain organoids kept on the space station developed neurons faster than cultures on Earth (NASA).
What has been made so far
The experiments are older than the industry. The first welding experiment in space flew on the Soviet Soyuz 6 mission, and materials research continued on Apollo and Skylab (NASA). In 1983, the shuttle Challenger made polystyrene "space beads" in a project between NASA and the US National Institute of Standards and Technology. NASA calls them one of the first products made in space and sold on Earth.
The space station brought companies in. On 24 November 2014, a 3D printer built by Made In Space printed its first part on the ISS. The part was a faceplate for the printer's own printhead (SpaceNews). Redwire bought Made In Space in 2020 (SpaceNews).
In 2017 Merck sent its cancer drug Keytruda to the station. In orbit it formed crystals of a single size. On Earth it formed two sizes at once. The result gave clues for turning the drug into an injection. But the Keytruda injection Merck launched in 2025 used a different approach (MIT Technology Review). The FDA approved that injection, Keytruda Qlex, on 19 September 2025 (FDA).
In 2024, hardware from Flawless Photonics drew more than 11 km of ZBLAN fibre on the station. Seven of the draws were longer than 700 m. Earlier attempts had managed about 20 m (The Register).
Getting it home
Making something in orbit is only useful if you can bring it back. Landing a capsule takes a licence, a place to land, and a heat shield.
Varda's first capsule shows how hard the paperwork is. W-1 launched in June 2023 and made crystals of the HIV drug ritonavir in orbit (Varda). In September 2023 the US Air Force refused it permission to land at its Utah test range, and the FAA had not granted a reentry licence (Payload). The capsule stayed in orbit. In February 2024, after one rejected application, the FAA licensed the landing (SpaceNews). It came down in Utah, the first commercial spacecraft to land on a military test range (Varda). Varda now has FAA permission to bring capsules back through 2029 (Varda).
Regulators are starting to plan for this. In March 2026 the UK set out a pathway for medicines made in space. It includes a re-entry sandbox run by the Civil Aviation Authority (UK government).
The capsules themselves are still new. Payload counts about a dozen startups working on reentry vehicles (Payload). SpaceX launched a demonstration of its own, Starfall, in June 2026. Each Starfall capsule is designed to carry 1,000 kg and come down in the Pacific (Spaceflight Now). SpaceX had not said how the demonstration went when Payload reported on it.
Who's working on it
Only a few companies in our directory are trying to make products in orbit. The rest build the labs, the return capsules and the tools around them.
Making products. Varda Space processes drugs inside capsules it brings back to Earth. W-7, launched in October 2026, is testing whether microgravity helps a new type of cancer medicine called a PROTAC dissolve better (Varda). Several of its recent capsules have carried payloads for the US government. W-5, for example, carried one for the US Navy (Varda). Space Forge grows semiconductor crystals in orbit. Its first satellite, ForgeStar-1, fired up its small furnace in December 2025 (Space.com) and had generated plasma more than 100 times by March 2026 (Space Forge). ForgeStar-1 cannot return anything. ForgeStar-2 is meant to make the first batch of semiconductor material, and ESA is funding a mission to test Space Forge's fold-out heat shield (Bdaily). BioOrbit has built a microwave-sized unit that crystallises cancer drugs in orbit. It wants to turn existing drugs into versions that can be injected under the skin (Payload). In 2026 a BioOrbit unit went to the space station on SpaceX's CRS-34 cargo flight (Phoenix Court). Made In Space's work continues inside Redwire. Redwire has flown 43 of its PIL-BOX drug crystallisation labs (Redwire), and it has booked up to 32 on a Starfall flight in 2028 (Payload).
Labs and return. SpacePharma builds small laboratories that fly experiments to the space station. In May 2026 it launched its 14th mission and, for the first time, had two labs in space at once (Davidson Institute). ElevationSpace in Japan is building an uncrewed platform for research and manufacturing that can return its contents to Earth (Payload). Atmos Space Cargo builds return capsules with inflatable heat shields. Its first, Phoenix 1, flew in April 2025 and sent back data from four payloads (European Spaceflight).
Building in orbit. ArcSpace and ThinkOrbital work on welding in orbit, to repair and assemble structures there rather than make products for Earth. ArcSpace is developing compact electron-beam tools and plans a test in orbit in 2027 (European Spaceflight). ThinkOrbital flew an autonomous welding system on a Falcon 9 in May 2024 (ThinkOrbital). It was named a Space Force STRATFI awardee in 2026 for in-space assembly (Payload).
The latest from each company
Varda SpaceUnited States
Orbital manufacturing
Space ForgeUnited Kingdom
Semiconductors made in orbit
- Company 17 August 2026 Signs a master research agreement with the Texas A&M University System, a first step to US semiconductor-materials production source
- Achievement December 2025 Fires its orbital furnace to 1,000°C and generates plasma on ForgeStar-1, a first for commercial in-space manufacturing source
Made In SpaceAcquiredUnited States
In-space manufacturing
ElevationSpaceJapan
Bringing orbit-made materials home
Atmos Space CargoGermany
Reentry capsules for orbital cargo
SpacePharmaSwitzerland
Microgravity labs and research
ThinkOrbitalUnited States
In-space welding and construction
The latest milestones from each company's record. The newest is from 5 November 2026.
How close are we?
Nothing made in orbit is on sale today. In May 2026, Varda's chief strategy officer, Michael Reilly, told MIT Technology Review: "I can't name anything manufactured in space, brought down to Earth, and sold" (MIT Technology Review). The 1983 space beads are the main exception, and they were a government project.
In May 2026 Varda signed up United Therapeutics as a customer, to test whether its lung medicines crystallise differently in microgravity. Reilly said Varda expected to launch United Therapeutics' drugs early in 2027 (MIT Technology Review). Varda's CEO, Will Bruey, has said he doesn't expect the first patient to receive a drug made this way before 2030 at the soonest (Aerospace America). BioOrbit's founder expects regulators to take about five years before clinical trials of its drugs can begin (Payload).
Flawless Photonics said in 2024 that its fibre would be tested and sold once it returned to Earth (The Register). We found no report of a sale.
What to watch
- The return of Varda's W-7 and W-9. W-7 carries the cancer-drug experiment. Both were still in orbit when W-8 landed on 5 November 2026 after 35 days (Varda)
- The first United Therapeutics drug flight on Varda, expected in 2027
- ElevationSpace's first platform, AOBA, which Payload reported would be ready to launch in 2026
- Results from BioOrbit's space station flight, and up to two more missions in 2027
- Space Forge's ForgeStar-2 and its heat shield test
- Redwire's 32 drug labs on Starfall, in 2028